TMV logo

Direxion Daily 20+ Year Treasury Bear 3x Shares (TMV)

$42.79

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on TMV

AUM

$203126013

P/E ratio

--

Dividend yield

2.2828%

Expense ratio

0.97%

Beta

-1.531968

Price on TMV

Previous close

$42.88

Today's open

$42.75

Day's range

$42.62 - $43.07

52 week range

$31.82 - $44.43

Profile about TMV

show more

Headquarters

US

Exchange

NYSE Arca

Issue type

Exchange-Traded Fund

TMV industries and sectors

Alternatives

Trading Tools

Top holdings in TMV
News on TMV

Inverse Treasury ETFs Likely to Shine Amid Rising Bond Yields

Rising oil prices, inflation fears and higher Treasury yields are creating a favorable backdrop for inverse Treasury ETFs.

news source

Zacks Investment Research • Aug 18, 2026

news preview

Market Brief: The Quarter's Most Pivotal 48 Hours

On Wednesday, July 29, the FOMC rate decision will be followed by Microsoft and Meta earnings after the close. Thursday begins with the advance estimate of Q2 GDP and the June PCE inflation report before Apple and Amazon report after the bell. CME FedWatch currently implies a 62–65% probability that the Fed holds rates in July, with the remaining probability assigned to a hike.

news source

Seeking Alpha • Jul 28, 2026

news preview

Yields Rise on Middle East Crisis: Inverse Treasury ETFs to Buy

Treasury yields climbed as Middle East tensions linger. These inverse Treasury ETFs could benefit if inflation and bond yields keep rising.

news source

Zacks Investment Research • Jul 22, 2026

news preview

Weave Bio Expands Strategic Advisory Board with Two Former FDA Leaders

SAN FRANCISCO--(BUSINESS WIRE)---- $TMV #AI--Weave Bio, a leader in AI-native regulatory automation for drug development, today announced the expansion of its Strategic Advisory Board (SAB) with the appointment of two former U.S. Food and Drug Administration leaders, Tala Fakhouri, Ph.D., M.P.H. chief AI and regulatory strategy officer at Parexel, and Sean Khozin, M.D., M.P.H., chief executive officer of the CEO Roundtable on Cancer and Project Data Sphere. Their appointments give the company firsthand insi.

news source

Business Wire • Jul 16, 2026

news preview

Treasury Yields Climb as Middle East Tensions Escalate: ETFs to Gain

Treasury yields surge as U.S.-Iran tensions lift oil prices. These ETFs could help investors navigate a rising-rate environment.

news source

Zacks Investment Research • Jul 9, 2026

news preview

Rate Hike Risks Are Rife? ETF Strategies to Play

Rising inflation and hawkish Fed signals are reviving rate-hike fears. These ETFs may help investors navigate a higher-yield environment.

news source

Zacks Investment Research • Jun 8, 2026

news preview

TMV: The S&P 500 Crash Hedge No One's Talking About, Until Now

Inverse, leveraged ETFs like the Direxion Daily 20+ Year Treasury Bear 3x ETF can effectively protect a bond ladder from inflation and rising interest rates. Many investors focus heavily on speculative growth stocks while missing rare, low-risk opportunities in bond ladders. Mid-2026 is an ideal time to build a US Treasury bond ladder to lock in stable, multi-decade returns.

news source

Seeking Alpha • Jun 2, 2026

news preview

ETFs to Play as U.S. Inflation Pressures Intensify

Sticky inflation and rising rate fears are putting pressure on markets. These ETFs may help investors navigate a higher-rate environment.

news source

Zacks Investment Research • Jun 2, 2026

news preview

How to Play Rising Treasury Yields With ETFs

There was a sharp rise in Treasury yields last week, with the 30-year Treasury yield climbing above 5.1% on May 15, 2026. Investor concerns intensified after a series of economic reports suggested inflationary pressures were picking up again, partly due to elevated oil prices linked to Middle East tensions.

news source

Zacks Investment Research • May 18, 2026

news preview

Weave Bio Establishes Inaugural Strategic Advisory Board to Shape the Future of AI-Driven Regulatory Science

SAN FRANCISCO--(BUSINESS WIRE)---- $TMV #AIinPharma--Weave Bio, the leader in AI-native regulatory automation, today announced the formation of its inaugural Strategic Advisory Board (SAB). Bringing together senior executives and thought leaders with expertise spanning pharma regulatory strategy and operations, health authority policy and practice, capital markets, and academic research, the SAB will serve as a strategic forum to guide the evolution of the Weave Platform and advance the responsible adoption of AI a.

news source

Business Wire • Mar 25, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Direxion Daily 20+ Year Treasury Bear 3x Shares

Open an M1 investment account to buy and sell Direxion Daily 20+ Year Treasury Bear 3x Shares commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in TMV on M1